# Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)

> **NCT07469865** · NA · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 46 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Preservative-free artificial tears
- **DRUG:** Autologous serum eyedrops 20%
- **DRUG:** Autologous serum eyedrops 100%

## Key facts

- **NCT ID:** NCT07469865
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2024-11-14
- **Final completion:** 2025-12-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07469865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07469865, "Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07469865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*